Clinical Trial Update: A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MH004 Ointment for mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MH004 Ointment

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: COMPLETED